Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection.
about
Antiviral therapy for symptomatic congenital cytomegalovirus infection in neonates and infants up to 3 months of ageClinical and radiologic evaluation of cytomegalovirus-induced thrombocytopenia in infants between 1 and 6 months of age.Trends in hospitalizations for diagnosed congenital cytomegalovirus in infants and children in AustraliaIsolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatmentHCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB.Seroprevalence of Cytomegalovirus among pregnant women and hospitalized children in PalestineCongenital cytomegalovirus infection: clinical outcomeReview of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.Effects of cytomegalovirus (CMV) related deafness on pediatric cochlear implant outcomes.Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model.Congenital cytomegalovirus infection: update on management strategiesThe "silent" global burden of congenital cytomegalovirus.Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.Treatment of congenital cytomegalovirus: where are we now?Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women.Cytomegalovirus frequency in neonatal intrahepatic cholestasis determined by serology, histology, immunohistochemistry and PCRCytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection.HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection.Central nervous system disorders in infants with congenital cytomegalovirus infection.Congenital cytomegalovirus infection: treatment, sequelae and follow-up.Optimum treatment of congenital cytomegalovirus infection.Severe neonatal cytomegalovirus infection: about a case.Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.Clinical Predictors of Sensorineural Hearing Loss and Cognitive Outcome in Infants with Symptomatic Congenital Cytomegalovirus Infection.Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women.Hearing configuration in children with cCMV infection and proposal of a flow chart for hearing evaluation.Cytomegalovirus glycoprotein H genotype distribution and the relationship with hearing loss in children.Clinical Significance of IgG Avidity Testing and Other Considerations in the Diagnosis of Congenital Cytomegalovirus Infection: A Review UpdatePathogenesis of Non-Zika Congenital Viral Infections.Inner ear lesions in congenital cytomegalovirus infection of human fetuses.Induction of cytomegalovirus-infected labyrinthitis in newborn mice by lipopolysaccharide: a model for hearing loss in congenital CMV infection.Vestibular-evoked myogenic potentials and caloric stimulation in infants with congenital cytomegalovirus infection.GJB2 and GJB6 mutations in children with congenital cytomegalovirus infection.
P2860
Q24248089-E6C02E06-BFE2-4588-85ED-2447DC421784Q33393054-59FFECB9-BF04-4FA2-A6DA-187DBECEF39EQ33403097-A5E3747A-4C21-4FA8-B7F7-C9EA4C688F3DQ33558361-BD4D85CB-363F-414E-B5ED-CAABD5871BF7Q33568646-083AF03A-62FA-4C4E-8C71-0785DB81722BQ33701853-19D313C6-AF27-45DA-9458-33E9E414ABDCQ35037239-8F39E45C-40ED-414A-9C61-BA8A63AAEC8FQ35753496-543FF39C-4805-4AA3-A663-C39691B0A238Q35828035-7269635C-AFED-40BF-A109-AEF0441B9D20Q36344951-D4A9DEC8-08E8-41D1-AEDB-A0F89B07F8D7Q36355613-CBDD71B3-3937-4AD4-9430-63BD7BA7662AQ36517138-2E79B03B-2A52-43CC-88D7-D45EEC57FC7DQ36558293-3B144B56-38A5-4396-80A6-CF9CB1A97D42Q36834814-7C397A9E-2419-47A1-AE4E-F01FE0709467Q36839732-FFCAE6F6-12C4-44A0-B7CA-CB992A3A195BQ37132000-E21D6EFE-F7BF-4948-9A18-77D5B6D48525Q37267460-25D40587-A83A-4433-BAB2-9CE43489EB42Q37377204-E44F6DEC-C463-42EC-84AA-1271CC35CA26Q37673149-505CCC6C-021C-4BF9-BDAE-B886C314F9DBQ37696737-9C4C37D6-F4D7-48EA-A384-2063DC192F80Q37734629-92A4F3D1-A76F-437D-B38C-0B66E07C45EFQ37784231-F6275D8D-EB46-4B06-A1D5-6DB12CC3A3A4Q38797872-465319B1-36AF-476F-B6FD-D09B96F67412Q40047616-B5084EC9-8DAA-4761-AEA5-7FB853C31FB6Q40337545-5E2ABC7E-F7AE-4974-9194-C4491EF2882FQ40668171-28A90489-6CA3-41EA-B3EB-77CF8A9AF330Q41107880-118CCD48-EA05-4C70-96FE-B06E10B40EAEQ41167019-AE033FEC-BEA5-4100-8CFC-F5A2E2F8C722Q42224684-32F7BB79-517D-43B7-AEA0-DDF6C5F862A2Q42705649-994AC77A-7E68-4E00-9E4B-8AFF9D1698FCQ47558368-B445A52F-12E2-45AA-8D2D-B7C2D0D4A3A5Q48811945-D69B5574-7C35-492A-90DE-9C0EC7D345AAQ50451824-1FD29642-E2A1-4CF2-B245-7BB4FB3BEEB8Q50455564-F6C842ED-5872-45F4-A197-00B400CE3A76Q50458112-7544B03A-DF3A-4405-896D-816474F3FE1A
P2860
Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@ast
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@en
type
label
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@ast
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@en
prefLabel
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@ast
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@en
P2093
P356
P1433
P1476
Predictors of hearing loss in ...... tal cytomegalovirus infection.
@en
P2093
Karen B Fowler
Lisa B Rivera
Robert F Pass
Sergio Stagno
Suresh B Boppana
William J Britt
P304
P356
10.1542/PEDS.110.4.762
P407
P577
2002-10-01T00:00:00Z